|
Market Closed -
Nasdaq Stockholm
02:00:00 19/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 12.80 SEK | -0.31% |
|
-3.61% | -57.48% |
| 16/09 | 11 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| 14/09 | US Regulator Accepts Orexo's New Drug Application for Anaphylaxis Treatment | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 45.32M | - | - | |||
| 362B | |||||
| 64.74B | |||||
| 12.76B | |||||
| 7.53B | |||||
| 4.38B |
- Stock Market
- Stocks
- ORX Stock
- Charts Orexo AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
